| Literature DB >> 32691131 |
Sara Torretta1,2, Pasquale Capaccio3,4, Ilaria Coro5,6, Samantha Bosis5, Maria Elisabetta Pace5,6, Pietro Bosi5,6, Lorenzo Pignataro3,7, Paola Marchisio5,6.
Abstract
Given COVID-19 pandemic periodic outpatient assessment of otitis-prone children regularly followed at our tertiary outpatient clinic of upper respiratory tract infections was discontinued since 9 March. In order to avoid leaving the patients to themselves just during the winter months, which are the most critical ones for these children, we kept in touch with the families of 102 children (mean age 41.4 ± 14.0 months) who had had a follow-up visit scheduled during the lockdown, and compensated with telemedicine assessment. This incidentally leads to the unexpected but not at all negative finding that a consistent clinical improvement had been occurred in most (82.3%) of children. A statistically significant reduction in the mean number of documented acute otitis media episodes, otorrhea episodes, and systemic antibiotic treatments during the February-April 2020 period compared with February-April 2019 was attested. Clinical evaluation performed in 27.4% cases revealed normal middle ear findings in all but three (89.3%) children.Entities:
Keywords: COVID-19; Children; Infection; Otitis media; Otitis-prone
Year: 2020 PMID: 32691131 PMCID: PMC7370867 DOI: 10.1007/s00431-020-03747-9
Source DB: PubMed Journal: Eur J Pediatr ISSN: 0340-6199 Impact factor: 3.183
Demographic and clinical characteristics of the patients and comparison between periods in terms of number of episodes of acute otitis media (AOM) without spontaneous tympanic membrane perforation, otorrhea episodes, and antibiotic treatments (SD: standard deviation).
| Characteristics | Number (%) | ||
|---|---|---|---|
| Mean age (SD), months | 41.4 (14.0) | ||
| Males | 51 (50.0%) | ||
| Prematurity | 5 (4.9) | ||
| Low weight at birth | 3 (2.9) | ||
| Breast-feeding | 82 (80.4) | ||
| Older siblings | 54 (52.3) | ||
| Order of geniture | 1st | 48 (47.1) | |
| 2nd | 48 (47.1) | ||
| 3rd | 6 (5.8) | ||
| Use of pacifier | 41 (40.2) | ||
| Use of push-and-pull bottle | 36 (37.5) | ||
| Second/third smoke exposure | 28 (27.7) | ||
| Familiarity for allergy | 50 (49.5) | ||
| Increased IgE levels | 34 (38.2) | ||
| Immunological defect | 6 (6.5) | ||
| Day-care attendance | 102 (100) | ||
| Adenoidal disease | 14 (13.7) | ||
| Hexavalent-vaccination | 102 (100) | ||
| Anti-pneumococcal vaccination | 102 (100) | ||
| Flu vaccination (winter 2019–2020) | 60 (60.6) | ||
| Comparison between periods | February–April 2019 | February–April 2020 | |
| Mean no. of AOM episodes/month (SD) | 0.37 (0.64) | 0.07 (0.35) | < 0.001 |
| Mean no. of otorrhea episodes/month (SD) | 0.48 (0.80) | 0.01 (0.09) | < 0.001 |
| Mean no. of antibiotics/month (SD) | 0.85 (0.88) | 0.09 (0.38) | < 0.001 |